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The propensity for occlusive thrombus formation is enhanced in conditions like myocardial infarction, stroke and renal disease. Blood from such 
patients not only demonstrates enhanced thrombus formation in vitro, but also once formed, thrombus is refractory to endogenous thrombolysis. 
In comparison, it is not known how global thrombotic status compares in patients with atrial fibrillation (AF), where the mechanism of thrombus 
formation involves low shear.
We tested global thrombotic status in patients with AF (n=44), stable coronary artery (CAD, n= 31), and healthy volunteers (n=82). Both AF and the 
CAD patients were taking aspirin 75mg daily as their sole antithrombotic medication. Healthy volunteers were on no treatment.
Thrombotic status was assessed by testing a blood sample with the point-of-care Global Thrombosis Test (GTT). This automated test employs non-
anticoagulated blood to assess thrombotic and thrombolytic status, by measuring the time required to form a shear-induced thrombus under 
physiological conditions, (occlusion time, OT), and in the second phase of the test, measuring the time to achieve endogenous lysis of the thrombus 
(lysis time, LT).
In AF patients, median OT was 447s (25th -75th %ile 347-555) and LT was 1472s (1145-2121). In CAD patients OT was 353s (300-441) and LT 
1654s (1138-2247). In healthy volunteers, OT was 363s (307-418) and LT was 1052s (896-1256). OT was similar in CAD and in healthy volunteers 
(P=0.468) but in AF, OT was prolonged compared to normal volunteers (P=0.004) and compared to CAD patients (P=0.005). LT is prolonged in AF 
patients compared to N volunteers (P<0.0001) and prolonged in CAD compared to healthy volunteers (P<0.0001). There was no difference in LT 
between CAD and AF patients (P=0.598)
In CAD patients, occlusion time is similar to normal volunteers. The former are on aspirin, suggesting that aspirin in CAD patients, brings the platelet 
reactivity to high shear back to the normal range. In patients with AF, occlusion time is prolonged compared to normal volunteers and CAD patients. 
This may reflect the fact that blood from AF patients shows reduced platelet reactivity at high shear. However, endogenous thrombolysis is impaired 
in both CAD and LT.
